TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/03 | 2022/03 | 2021/03 |
Turnover |
43,802
|
41,152
|
48,028 |
Financial expenses |
158
|
724
|
563 |
Earnings before taxes |
1,997
|
1,468
|
2,283 |
EBITDA |
2,155
|
1,509
|
2,426 |
Total assets |
56,098
|
45,224
|
43,543 |
Current assets |
56,098
|
45,224
|
43,543 |
Current liabilities |
18,274
|
10,864
|
10,177 |
Equity capital |
37,824
|
34,360
|
33,367 |
- share capital |
248
|
227
|
225 |
Employees (average) |
16
|
18
|
19 |
Financial ratios
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Solvency |
67.4%
|
76.0%
|
76.6% |
Turnover per employee |
2,738
|
2,286
|
2,528 |
Profit as a percentage of turnover |
4.6%
|
3.6%
|
4.8% |
Return on assets (ROA) |
3.8%
|
4.8%
|
6.5% |
Current ratio |
307.0%
|
416.3%
|
427.9% |
Return on equity (ROE) |
5.3%
|
4.3%
|
6.8% |
Change turnover |
2,650
|
-6,876
|
-16,681 |
Change turnover % |
6%
|
-14%
|
-26% |
Chg. No. of employees |
-2
|
-1
![]() |
-1 |
Chg. No. of employees % |
-11%
|
-5%
![]() |
-5% |
Total value of public sale
Fiscal year | 2023/03 | 2022/03 | 2021/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.